Heart Test Laboratories, Inc. d/b/a HeartSciences is a medical technology company focused on applying innovative AI-based technology to an ECG (also known as an EKG) to expand and improve an ECG's clinical utility. Millions of ECGs are performed every week and the Company's objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. HeartSciences has one of the largest libraries of AI-ECG algorithms and is developing AI-ECG solutions to be made available on either a hardware agnostic cloud-based platform or its proprietary MyoVista? wavECG(TM) device, to help identify cardiovascular disease in any care setting worldwide in a manner to best suit different care providers. HeartSciences' first product candidate for FDA clearance, the MyoVista? wavECG(TM), or the MyoVista(R), is a resting 12-lead ECG that is also designed to provide diagnostic information related to cardiac dysfunction.
| Revenue (Most Recent Fiscal Year) | $0.02M |
| Net Income (Most Recent Fiscal Year) | $-6.61M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | -- |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 2.00 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -50833.34% |
| Net Margin (Trailing 12 Months) | -- |
| Return on Equity (Trailing 12 Months) | -178.80% |
| Return on Assets (Trailing 12 Months) | -109.28% |
| Current Ratio (Most Recent Fiscal Quarter) | 1.02 |
| Quick Ratio (Most Recent Fiscal Quarter) | 0.83 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.00 |
| Inventory Turnover (Trailing 12 Months) | 0.00 |
| Book Value per Share (Most Recent Fiscal Quarter) | $11.16 |
| Earnings per Share (Most Recent Fiscal Quarter) | $-2.57 |
| Earnings per Share (Most Recent Fiscal Year) | $-19.00 |
| Diluted Earnings per Share (Trailing 12 Months) | $-7.48 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Devices |
| Common Shares Outstanding | 1.08M |
| Free Float | 1.06M |
| Market Capitalization | $3.95M |
| Average Volume (Last 20 Days) | 0.02M |
| Beta (Past 60 Months) | 2.61 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 1.80% |
| Percentage Held By Institutions (Latest 13F Reports) | 17.24% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |